Ann: Receipt of R&D Tax Incentive payment, page-27

Hate I was right about the sp by 31 Jan. I also stand by my comment re. MD. This stock will not go anywhere but south with him at the helm. I wholeheartedly believe that just replacing MD (and leaving all other things the same) will result in a re-rate in this company. I believe if it was announced that MD is out and would be replaced with someone competent, this sp would go to 8-10 cents within a week (two tops) on that alone.

Unfortunately, I still see further downside for this stock. With no positive news in Feb/March, this stock I believe will sink into the 4's during this period.

I wish I could sell the last of my shares, but it's uneconomical to do so. 80 residual shares.....sigh.

I will note that I am only keeping an interest in this stock because I believe in RNA based biotech and this company has shown pretty decent results with its trials and through all it's been, I know this company's sp should be sitting in the $50-100mil range atm. I really do believe in the tech, but the influence of MD is too large to ignore, and hence why I don't foresee myself taking a buy position in this company till he leaves, or something major happens (even then with MD at the helm, I'd be hesitant to buy).